CAPLIPOINT — Caplin Point Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹174.93bn
- IN₹164.61bn
- IN₹21.87bn
Brief: Caplin Point Laboratories Unit Gets USFDA Nod For Ropivacaine Hydrochloride Injection
Caplin Steriles Gets USFDA Approval For Verapamil Hydrochloride Injection USP
India's Caplin Point Laboratories soars after Q3 profit, says no impact from coronavirus
Brief: India's Caplin Point Laboratories Dec Qtr Consol Net Profit Rises
Brief: Caplin Point Laboratories Ltd Says Unit Gets USFDA Approval For Sodium Nitroprusside Injection
India's Caplin Point Laboratories rises after Q1 profit jump
Brief: India's Caplin Point Laboratories June-Qtr Consol Net Profit Rises
Brief: Caplin Point Laboratories Gets Establishment Inspection Report For Injectable Facility
Brief: Caplin Point Labs Says Caplin Steriles Gets USFDA Approval For Tranexamic Acid Injection
Brief: Caplin Point Laboratories Gets Two Observations Post USFDA Inspection At Steriles Injectable Site
Brief: Caplin Point Laboratories Gets Colombia Approval For Sterile Injectables
Brief: Caplin Point Laboratories Unit Enters License And Supply Deal With Baxter Healthcare
Brief: Caplin Point Laboratories Says Caplin Steriles Gets USFDA Nod For Glycopyrrolate Injection
Brief: India's Caplin Point Laboratories Dec-Qtr Consol Profit Rises
Brief: Caplin Point Laboratories Aprpoves Business Transfer Agreement With Caplin Steriles
Brief: Caplin Point Laboratories To Consider Entering Deal With Caplin Steriles To Transfer Co's Business Undertaking
Brief: Caplin Point Laboratories Gets Shareholders' Nod For Transfer Of Business Undertaking To Unit
Brief: Caplin Point Laboratories Incorporates Subsidiary Caplin Steriles
Brief: Caplin Point Laboratories Approves Slump Sale Of Co's Business Undertaking To Unit